Sarepta Therapeutics | SRPT - Créances Commerciales





Créances Commerciales Changement Date
Acadia Pharmaceuticals USD 148.38M 153K 2026-03
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Alnylam Pharmaceuticals USD 883.96M 106.39M 2026-03
Amgen USD 9.14B 432M 2026-03
BioCryst Pharmaceuticals USD 106.82M 15.49M 2025-12
Biogen USD 1.79B 76.6M 2026-03
BioMarin Pharmaceutical USD 903.91M 4.3M 2026-03
Capricor Therapeutics USD 59K 0 2025-12
Daiichi Sankyo JPY 695.95B 79.1B 2025-12
Eli Lilly USD 21.18B 1.02B 2026-03
Esperion Therapeutics USD 140.19M 21.21M 2025-12
Gilead Sciences USD 4.74B 172M 2026-03
Incyte USD 1.05B 27.09M 2026-03
Insmed USD 178.55M 37.7M 2026-03
Ionis Pharmaceuticals USD 74M 8M 2026-03
Moderna USD 71M 113M 2026-03
Nektar Therapeutics USD 1.78M 1.12M 2025-12
Neurocrine Biosciences USD 768.1M 81.3M 2026-03
Novavax USD 106.45M 72.27M 2025-12
Pfizer USD 16.17B 332M 2026-03
PTC Therapeutics USD 181.62M 21.45M 2025-12
Regeneron Pharmaceuticals USD 5.73B 10.1M 2026-03
Roche Holding CHF 11.9B 460M 2025-12
Sangamo BioSciences USD 581K 110K 2024-06
Sanofi EUR 482M 85M 2026-03
Sarepta Therapeutics USD 547.91M 149.68M 2026-03
Tectonic Therapeutic USD 0 270K 2023-12
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
Vertex Pharmaceuticals USD 2B 56.7M 2026-03